mercaptoethanol has been researched along with ifosfamide in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 67 (84.81) | 18.7374 |
1990's | 12 (15.19) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brock, N; Pohl, J; Stekar, J | 2 |
Burkert, H; Fichtner, E; Schnitker, J | 1 |
Marti, C; Steiner, R; Viollier, AF | 1 |
Antman, KH; Begg, CB; Eder, JP; Elias, AD; Frei, E; Shea, T | 1 |
Goren, MP; Pratt, CB | 2 |
Fujiwara, F; Imashuku, S; Iwasaku-Fujimoto, M; Morioka, Y; Todo, S | 1 |
Dana, WJ; Schoenike, SE | 1 |
Araujo, CE; Brosto, M; Cervellino, JC; Pirisi, C; Rossi, R; Sanchez, O | 1 |
Aalders, JG; de Vries, EG; Neijt, JP; ten Bokkel Huinink, WW; vd Burg, ME; vd Gaast, A; Willemse, PH | 1 |
Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP | 2 |
Beauduin, M; Closon, MT; Focan, C; Majois, F; Michel, J; Paridaens, R; Piccart, M; Salamon, E; Tueni, E; Vindevoghel, A | 1 |
Milla, A; Sanchiz, F | 1 |
Dorr, RT | 1 |
Einhorn, LH; Loehrer, PJ; Munshi, N; Williams, SD | 1 |
Dhingra, HM; Glisson, BS; Holoye, PY; Hong, WK; Jeffries, D; Lee, JS; Levy, JK; Murphy, WK; Raber, MN; Umsawasdi, T | 1 |
Antman, KH; Elias, A; Grier, HE; Ryan, L; Sherman, D | 1 |
Boossy, J; Claessens, JJ; Focan, C; Focan-Henrard, D; Reginster, M | 1 |
Douglass, EC; Etcubanas, E; Goren, MP; Green, AA; Hayes, FA; Horowitz, ME; Meyer, WH; Pratt, CB; Thompson, EI; Wilimas, JA | 1 |
de Jong, PE; Elema, JD; Mulder, NH; Willemse, PH | 1 |
de Vries, EG; Willemse, PH | 1 |
Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K | 1 |
Falkson, CI; Falkson, G; Falkson, HC | 1 |
Berman, ML; Blessing, JA; Homesley, HD; Malfetano, J; Sutton, GP | 1 |
Dodge, RK; Goren, MP; Meyer, WH; Pratt, CB; Viar, MJ; Wright, RK | 1 |
Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Ruiz, JG; Verdeguer, A | 1 |
Blackledge, G; Blake, AE; Blake, DR; Honigsberger, L; Latief, TN; Meanwell, CA; Mould, JJ; Shaw, IC; Spooner, D; Williams, AC | 1 |
Cantwell, BM; Harris, AL | 1 |
Blackledge, G; Kelly, KA; Meanwell, CA | 1 |
Harrop, JS; Hill, PG | 1 |
Blackledge, G; Constantine, G; Meanwell, C | 1 |
Goren, MP; Horowitz, ME; Pratt, CB; Wright, RK | 1 |
Perren, TJ; Smith, IE; Turner, RC | 1 |
McCallum, AK | 1 |
Husband, DJ; Watkin, SW | 1 |
Brock, N; Dietrich, I; Hilgard, P; Manz, I; Niemeyer, U; Pohl, J; Przybylski, M | 1 |
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Palangie, T; Pouillart, P; Scholl, S | 1 |
Bozzino, JM; Cantwell, BM; Harris, AL | 1 |
Cantwell, BM; Harris, AL; Pooley, J | 1 |
Eguchi, K; Jett, JR; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suemasu, K; Tamura, T | 1 |
Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA | 1 |
Christian, E; Coerper, C; Dias Wickramanayake, P; Klein, HO | 1 |
Andriole, GL; Arasi, V; Linehan, M; Magrath, IT; Miser, JS; Sandlund, JT | 1 |
Brock, N; Pohl, J | 1 |
Akatchereian, C; Flamant, F; Ghosn, M; Salloum, E; Taleb, N | 1 |
De Forges, A; Droz, JP; Ghosn, M; Theodore, C | 1 |
Cantwell, BM; Carmichael, J; Ghani, S; Harris, AL | 1 |
Alberts, AS; Falkson, G; Van Zyl, L | 1 |
Anderson, J; Case, DC; Ervin, TJ; Gottlieb, A | 1 |
Carde, P; Droz, JP; Flamant, F; Friedman, S; Ghosn, M; Hayat, M; Leclerq, B | 1 |
Brock, N; Guan, ZZ; He, YJ; Li, GC; Li, JQ | 1 |
Abbruzzese, JL; Ajani, JA; Boman, BM; Faintuch, JS; Goudeau, P; Levin, B; Nicaise, C; Yeomans, AC | 1 |
Brade, WP; Dittrich, C; Herold, C; Keller, A; Mader, R; Moser, K; Schlappack, O; Steger, GG | 1 |
Bryant, BM; Ford, HT; Jarman, M; Smith, IE | 1 |
Rose, JW; Shaw, IC | 1 |
Adams, P; Bradford, E; Haines-Nutt, RP; Jakobson, K; Rowland, CG | 1 |
Araujo, CE; Tessler, J | 1 |
Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U | 1 |
Harper, PG; Kaye, SB; Stuart-Harris, R; Wiltshaw, E | 1 |
de Kraker, J; Voûte, PA | 1 |
Brock, N; Christian, E; Coerper, C; Klein, HO; Pohl, J; Wickramanayake, PD | 1 |
Burkert, H | 1 |
Christian, E; Coerper, C; Graf, L; Klein, HO; Wickramanayake, PD | 1 |
Bremer, K; Niederle, N; Scheulen, ME; Schütte, J; Seeber, S | 1 |
Gowing, NF; Harper, PG; Kaye, SB; Mooney, CA; Parsons, CA; Stuart-Harris, RC; Wiltshaw, E | 1 |
Calman, KC; Dalton, JF; Kaye, SB; Sangster, G | 1 |
Burkert, H; Hilgard, P | 1 |
Breuel, HP; Burkert, H; Lücker, PW; Wetzelsberger, N | 1 |
Brock, N | 1 |
Czownicki, Z; Utracka-Hutka, B | 1 |
Brock, N; Stekar, J | 1 |
Falkson, G; Falkson, HC; Stapelberg, R; Van Dyk, JJ | 1 |
Brock, N; Pohl, J; Scheef, W; Stekar, J | 1 |
2 review(s) available for mercaptoethanol and ifosfamide
Article | Year |
---|---|
Ifosfamide and mesna.
Topics: Animals; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1990 |
Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna; Mitomycins | 1990 |
9 trial(s) available for mercaptoethanol and ifosfamide
Article | Year |
---|---|
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Female; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1989 |
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
Topics: Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Mercaptoethanol; Mesna; Multicenter Studies as Topic; Ovarian Neoplasms; Platelet Count | 1989 |
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Mercaptoethanol; Mesna | 1986 |
The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
Topics: Adult; Aged; Clinical Trials as Topic; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Random Allocation | 1986 |
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Pancreatic Neoplasms | 1988 |
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Kinetics; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Phosphoramide Mustards; Urinary Bladder | 1980 |
Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Urinary Bladder Diseases | 1983 |
Clinical overview of mesna.
Topics: Clinical Trials as Topic; Cyclophosphamide; Drug Interactions; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
[Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
Topics: Clinical Trials as Topic; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1981 |
68 other study(ies) available for mercaptoethanol and ifosfamide
Article | Year |
---|---|
[Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
Topics: Animals; Antidotes; Carcinosarcoma; Cyclophosphamide; Ifosfamide; Mercaptoethanol; Mesna; Phosphoramide Mustards; Rats; Urine | 1979 |
[Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Phosphoramide Mustards; Testicular Neoplasms | 1979 |
[High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
Topics: Adult; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Osteosarcoma | 1979 |
High-dose ifosfamide with mesna uroprotection: a phase I study.
Topics: Blood; Bone Marrow; Central Nervous System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Time Factors; Urinary Tract | 1990 |
False-positive ketone tests: a bedside measure of urinary mesna.
Topics: Adolescent; Child; False Positive Reactions; Female; Humans; Ifosfamide; Ketones; Mercaptoethanol; Mesna | 1990 |
[Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Topics: Bone Neoplasms; Child; Cyclophosphamide; Cystitis; Female; Hematuria; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhabdomyosarcoma | 1990 |
Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Uterine Cervical Neoplasms | 1990 |
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1990 |
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
Topics: Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Sarcoma; Uterine Cervical Neoplasms | 1990 |
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1990 |
High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1990 |
Cyclophosphamide and ifosfamide: role of uroprotective agents.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Urogenital Neoplasms | 1990 |
Ifosfamide with mesna uroprotection in the management of lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Survival Rate; Urologic Diseases; Vincristine | 1990 |
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged | 1989 |
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
Topics: Adolescent; Child; Child, Preschool; Drug Evaluation; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Sarcoma | 1989 |
Severe renal failure following high-dose ifosfamide and mesna.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms | 1989 |
Mesna: continuous or bolus infusion?
Topics: Drug Administration Schedule; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Mercaptoethanol; Mesna; Sarcoma; Soft Tissue Neoplasms | 1989 |
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1989 |
Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urologic Diseases | 1989 |
Mesna excretion and ifosfamide nephrotoxicity in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Neoplasms; Proteinuria | 1989 |
Fatal encephalopathy with ifosfamide/mesna.
Topics: Brain Diseases; Child; Drug Therapy, Combination; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Rhabdomyosarcoma | 1989 |
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
Ifosfamide and mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cystitis; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1989 |
Encephalopathy associated with ifosphamide/mesna therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Uterine Neoplasms | 1985 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma | 1985 |
Ifosfamide, mesna, and encephalopathy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna | 1985 |
Avoiding ifosfamide/mesna encephalopathy.
Topics: Adolescent; Adult; Aged; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Probability | 1986 |
Ifosfamide/mesna nomogram and serum albumin.
Topics: Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Pelvic Inflammatory Disease; Serum Albumin | 1986 |
Ifosfamide/mesna nomogram and serum albumin.
Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Methods; Serum Albumin | 1986 |
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; CD13 Antigens; Child; Child, Preschool; Creatinine; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Kidney Tubules; Male; Mercaptoethanol; Mesna; Proteinuria | 1987 |
Encephalopathy with rapid infusion ifosfamide/mesna.
Topics: Brain Diseases; Drug Therapy, Combination; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna | 1987 |
Ifosfamide/mesna encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epilepsy, Tonic-Clonic; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Psychoses, Substance-Induced | 1987 |
Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
Topics: Drug Therapy, Combination; Humans; Hypokalemia; Ifosfamide; Male; Mercaptoethanol; Mesna | 1988 |
Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
Topics: Acrolein; Animals; Cyclophosphamide; Ifosfamide; Kinetics; Mass Spectrometry; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains | 1985 |
[Encephalopathy caused by an ifosfamide-mesna combination].
Topics: Adult; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1988 |
False-positive ketonuria during ifosfamide and mesna therapy.
Topics: False Positive Reactions; Female; Humans; Ifosfamide; Ketone Bodies; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged | 1986 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Soft Tissue Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1986 |
Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1986 |
Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
Topics: Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mercaptoethanol; Mesna; Middle Aged; Osteosarcoma; Soft Tissue Neoplasms | 1986 |
The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclophosphamide; Cystitis; Female; Hematuria; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms | 1987 |
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experimental; Mercaptoethanol; Mesna; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Irreversible encephalopathy with ifosfamide/mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Maxillary Neoplasms; Mercaptoethanol; Mesna; Rhabdomyosarcoma; Vincristine | 1987 |
Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged | 1987 |
Ifosfamide/mesna and hematuria.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hematuria; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna | 1987 |
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1988 |
Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Mesothelioma; Middle Aged; Pleural Neoplasms | 1988 |
Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Hematologic Diseases; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mercaptoethanol; Mesna; Middle Aged | 1988 |
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Topics: Adolescent; Brain Diseases; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Phenobarbital | 1988 |
Ifosfamide and Mesna in advanced malignancies.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms | 1988 |
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged | 1988 |
Infusion of ifosphamide plus mesna.
Topics: Cyclophosphamide; Drug Interactions; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna; Urinary Bladder Neoplasms | 1984 |
Infusion of ifosfamide plus mesna.
Topics: Cyclophosphamide; Drug Combinations; Drug Stability; Drug Storage; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna | 1984 |
Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
Topics: Animals; Cyclophosphamide; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna | 1983 |
High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1983 |
Ifosfamide, mesna and vincristine in paediatric oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Vincristine | 1983 |
High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
Topics: Cyclophosphamide; Drug Evaluation; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms | 1983 |
Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
Topics: Animals; Cyclophosphamide; Drug Therapy, Combination; Ifosfamide; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1983 |
Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
Topics: Cyclophosphamide; Drug Evaluation; Drug Interactions; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms; Testicular Neoplasms; Urinary Tract | 1983 |
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Kidney; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1983 |
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
Topics: Adult; Cyclophosphamide; Fanconi Syndrome; Female; Humans; Ifosfamide; Intestinal Neoplasms; Leiomyosarcoma; Mercaptoethanol; Mesna | 1984 |
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
Topics: Cyclophosphamide; Humans; Ifosfamide; Infusions, Parenteral; Kidney Diseases; Mercaptoethanol; Mesna | 1984 |
Bioavailability of orally administered mesna.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Biological Availability; Cyclophosphamide; Humans; Ifosfamide; Injections, Intravenous; Male; Mercaptoethanol; Mesna | 1984 |
The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cystitis; Erythrocyte Count; Ifosfamide; Mercaptoethanol; Mesna; Rats; Urologic Diseases | 1980 |
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
Topics: Animals; Cyclophosphamide; Cystitis; Female; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Rats; Urinary Bladder | 1981 |
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1982 |
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.
Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urinary Bladder Diseases | 1982 |
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
Topics: Animals; Cyclophosphamide; Dogs; Drug Interactions; Female; Ifosfamide; Kinetics; Lethal Dose 50; Male; Mercaptoethanol; Mesna; Mice; Neoplasms, Experimental; Proscillaridin; Rats; Urinary Bladder Diseases | 1982 |